Cassandra Dean, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 606 Biak Ave # 2, Garibaldi, OR 97118 Phone: 503-560-5937 |
News Archive
Food and Drug Administration (FDA) is currently reviewing the combination of extended release (ER) niacin and laropiprant under the trademark Cordaptive (ER niacin/laropiprant). The CHMP recommendation does not apply to regulatory decisions by the FDA and no inferences should be made about pending FDA regulatory actions based on the recommendation of the CHMP.
Researchers from Germany and the US investigated the efficacy of neutralizing antibodies against newer variants using serum and saliva samples obtained from groups of infected, vaccinated (with Pfizer BNT-162b2), and uninfected individuals. The researchers started this study to uncover vaccine-induced immune response and show the efficiency of antibody binding and neutralization in SARS-CoV-2 variants.
Lux Biosciences, Inc. today announced that the Dermatology and Ophthalmology Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) is scheduled to review its New Drug Application (NDA) for Luveniqâ„¢ (oral voclosporin) for the treatment of non-infectious uveitis involving the intermediate or posterior segments of the eye on June 28, 2010.
While radiation treatments deliver precise doses of high-energy X-rays to stop cancer cells from spreading or to shrink tumors, oncologists have become increasingly concerned about inadvertent exposures during head and neck cancer treatments to nerves responsible for upper body mobility.
Henry Schein Cares, the global corporate social responsibility program of Henry Schein, Inc., the world's largest provider of health care products and services to office-based dental, medical and animal health practitioners, is once again helping expand access to quality oral health care for underserved and at-risk populations through the Calendar of Caring Community Wellness Program.
› Verified 9 days ago